2024
Psychotherapeutic Interventions in Clinical Trials of Psychedelics for the Treatment of Alcohol Use Disorder
Mohammad Aghaei A, Weleff J, Martins B, Ing K, Fontenele R, Barnett B, Anand A, Bassir Nia A. Psychotherapeutic Interventions in Clinical Trials of Psychedelics for the Treatment of Alcohol Use Disorder. Current Addiction Reports 2024, 11: 685-712. DOI: 10.1007/s40429-024-00574-y.Peer-Reviewed Original ResearchTreatment of AUDUse disorderTreatment of alcohol use disordersModalities of psychotherapyAlcohol use disorderPsychedelic treatmentPsychotherapeutic interventionsTreat AUDPsychedelic compoundsPsychedelic trialsPsychotherapySmall numbers of participantsPsychedelicsMagnitude of improvementMethodological shortcomingsAUDNumbers of participantsClinical trialsDisordersReviewed trialsShort follow-up periodFollow-up periodTherapy methodsEmpirical evidenceNo significant difference
2023
Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges
Barnett B, Nia A, Sackett N, Weleff J. Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges. Frontiers In Psychiatry 2023, 14: 1305478. PMID: 37928914, PMCID: PMC10622752, DOI: 10.3389/fpsyt.2023.1305478.Peer-Reviewed Original Research
2022
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies
Weleff J, Akiki T, Barnett B. Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies. Journal Of Psychoactive Drugs 2022, 55: 434-444. PMID: 36218281, DOI: 10.1080/02791072.2022.2133757.Peer-Reviewed Original ResearchLysergic acid diethylamidePsychedelic researchBibliometric analysisEffects of psychedelicsStudies of psychedelicsClinical psychedelic researchNon-research settingsPsychiatric treatmentN-dimethyltryptamineProportion of studiesAcid diethylamidePsilocybinPsychedelicsSubanalysis of studiesPsilocybin studiesDimethyltryptamineMDMARelevant articlesMescalinePsychedelics in the Treatment of Substance Use Disorders
Barnett B, Weleff J. Psychedelics in the Treatment of Substance Use Disorders. Psychiatric Annals 2022, 52: 365-370. DOI: 10.3928/00485713-20220804-01.Peer-Reviewed Original ResearchSubstance use disordersPsychedelic experienceTreatment of substance use disordersLysergic acid diethylamideSubjective effectsUse disorderAcid diethylamidePlacebo-controlled trialPsychedelicsBehavioral changesTherapeutic potentialClinician concernsLife narrativesDisordersFacilitation programTreatment paradigmTherapeutic efficacyClinical trialsTreatment potentialObservational studyPsilocybinDiethylamideTrialsSubstancesOpioid